SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
61 hedge funds and large institutions have $64M invested in Sierra Oncology, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+1
Holders Change %
+1.67%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
10
Increased
13
Reduced
19
Closed
9
Calls
$30K
Puts
$83K
Net Calls
-$53K
Net Calls Change
-$87K
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
$4.87M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
$2.64M |
| 3 |
AC
Armistice Capital
New York
|
$2.11M |
| 4 |
BC
Broadfin Capital
New York
|
$6.44M |
| 5 |
6CM
683 Capital Management
New York
|
$2.87M |
